All of the following antidiabetic drugs act by enhancing insulin resistance except
Refer KDT 7th /270 Rosiglitaxzone does not act by increasing insulin secretion Rosiglitazone is an oral antihyperglycemic agent that acts primarily by decreasing insulin resistance
Exenatide
Sitagliptan
Rosiglitazone
Repaglinide
Endocrinology